PharmaShots Weekly Snapshot (May 20-24, 2019)
1.BrightInsight Launches a CE-Marked Dosing Calculator for Emicizumab to Treat Patients with Hemophilia A
Published: May 23, 2019 | Tags: BrightInsight, Launches, CE-Marked, Dosing Calculator, Emicizumab, Treat, Patients, Hemophilia A
2. Roches Cobas TV/MG Test Receives FDAs 510 (k) Clearance for the Detection of Sexually Transmitted Diseases
Published: May 23, 2019 | Tags: Roche, Cobas TV/MG Test, Receives, FDA, 510 (k), Clearance, Detection, Sexually Transmitted Diseases
3. Hologic & Cepheids Diagnostic Tests Receive 510(k) Clearance for Extragenital Testing in Chlamydia and Gonorrhea
Published: May 23, 2019 | Tags: Hologic, Cepheid, Diagnostic Tests, Receive, 510(k), Clearance, Extragenital Testing, Chlamydia, Gonorrhea
4. Celltrions Herzuma (trastuzumab, biosimilar) Receives ANVISAs Approval for Breast and Gastric Cancer in Brazil
Published: May 23, 2019 | Tags: Celltrion, Herzuma, trastuzumab, biosimilar, Receives, ANVISA, Approval, Brazil
5. GSKs Shingrix Receives NMPAs Approval for the Prevention of Shingles in China
Published: May 24, 2019 | Tags: GSK, Shingrix, Receives, NMPA, Approval, Prevention, Shingles, China
6. Boston Scientific Initiates OPTION Study of Watchman FLX Device for Stroke Risk Reduction Post-AF Ablation
Published: May 22, 2019 | Tags: Boston Scientific, Initiates, OPTION, Study, Watchman FLX, Device, Stroke Risk Reduction, Post-AFib Ablation
7. Synlogic Collaborates with Roche to Evaluate the Combination of SYNB1891 and Tecentriq (atezolizumab) for Advanced Solid Tumors
Published: May 22, 2019 | Tags: Synlogic, Collaborates, Roche, Evaluate, Combination, SYNB1891, Tecentriq, atezolizumab, Advanced Solid Tumors
8. OncoSec Reports Result of Keytruda + TAVO in P-II KEYNOTE-890 Study for Refractory Metastatic Triple Negative Breast Cancer
Published: May 22, 2019 | Tags: OncoSec, Reports, Result, Keytruda, TAVO, P-II, KEYNOTE-890, Study, Refractory, Metastatic, Triple Negative Breast Cancer
9. Santhera Signs an Exclusive License Agreement with Chiesi to Develop and Commercialize Raxone for Lebers Hereditary Optic Neuropathy
Published: May 23, 2019 | Tags: Santhera, Signs, License Agreement, Chiesi, Develop, Commercialize, Raxone, Lebers Hereditary Optic Neuropathy
10. Takedas Entyvio (vedolizumab) Receives MHLWs Approval for Moderate to Severely Active Crohns Disease in Japan
Published: May 22, 2019 | Tags: Takeda, Entyvio, vedolizumab, Receives, MHLW, Approval, Moderate, Severely, Active, Crohn, Disease, Japan
11. Biocon and Mylans Ogivri (trastuzumab, biosimilar) Receives Health Canadas Approval for HER2-Positive Breast and Gastric Cancers
Published: May 22, 2019 | Tags: Biocon, Mylan, Ogivri, trastuzumab, biosimilar, Receives, Health Canada, Approval, HER2-Positive, Breast,Gastric Cancers
12. Medtronic Reports Results of Symplicity Renal Denervation System in Two Studies for Hypertensive Heart Diseases
Published: May 22, 2019 | Tags: Medtronic, Reports, Results, Symplicity Renal Denervation System, Two Studies, Hypertensive Heart Diseases
13. Abbott Reports Results of Minimally Invasive Device in TRILUMINATE Study for Tricuspid Heart Valve Leaks
Published: May 21, 2019 | Tags: Abbott, Reports, Results, Minimally Invasive Device, TRILUMINATE, Study, Tricuspid Heart Valve Leaks
14. Array BioPharma Reports Results of Combination Therapy in P-III BEACON CRC Study for BRAF(V600E)- Mutant Metastatic Colorectal Cancer
Published: May 21, 2019 | Tags: Array BioPharma, Reports, Results, Combination Therapy, P-III, BEACON, CRC, Study, BRAFV600E Mutant, Metastatic Colorectal Cancer
15. Verily Collaborates with Global Pharma Companies to Develop Clinical Research Program
Published: May 21, 2019 | Tags: Verily, Collaborates, Big Pharma, Companies, Develop, Clinical Research Program
16. Merck to Acquire Peloton Therapeutics for $2.2B
Published: May 21, 2019 | Tags: Merck, Acquire, Peloton Therapeutics, $2.2B
17.Clovis Oncology Reports Results of Rubraca (rucaparib) in P-III ARIEL3 Study for Advanced Ovarian Cancer
Published: May 21, 2019 | Tags: Clovis Oncology, Reports, Results, Rubraca, rucaparib, P-III, ARIEL3, Study, Advanced, Ovarian Cancer
18. AstraZeneca Reports Results of Symbicort Turbuhaler (budesonide/formoterol) in Novel START Study for Mild Asthma
Published: May 20, 2019 | Tags: AstraZeneca, Reports, Results, Symbicort Turbuhaler, budesonide, formoterol, Novel START Study, Mild Asthma
19. Merck Reports Results of Keytruda (pembrolizumab) in P-III KEYNOTE-119 Study for Metastatic Triple-Negative Breast Cancer
Published: May 20, 2019 | Tags: Merck, Reports, Results, Keytruda, pembrolizumab, P-III, KEYNOTE-119, Study, Metastatic, Triple-Negative Breast Cancer
20. Santhera Signs a Pre-Clinical Research Agreement with Biozentrum to Advance Gene Therapy for Congenital Muscular Dystrophy
Published: May 20, 2019 | Tags: Santhera, Signs, Pre-Clinical, Research, Agreement, Biozentrum, Advance, Gene Therapy, Congenital Muscular Dystrophy
21. UCBs Nayzilam (midazolam) Receives FDAs Approval for the Treatment of Seizure Cluster in Epilepsy in the US
Published: May 20, 2019 | Tags: UCB, Nayzilam, midazolam, Receives, FDA, Approval, Treatment, Seizure Cluster, Epilepsy
22. Takedas Gattex (teduglutide) Receives the US FDAs Approval for Short Bowel Syndrome in Children
Published: May 17, 2019 | Tags: Takeda, Gattex, teduglutide, Receives, US FDA, Approval, Short Bowel Syndrome, Children
23. Ethicon (J&J) Recalls Endo-Surgery Intraluminal Staplers Due to Complete Staple Line Failure
Published: May 16, 2019 | Tags: Ethicon, J&J, Recalls, Endo, Surgery, Intraluminal Staplers, Complete, Staple, Line Failure
24. Takeda Reports Results of Entyvio (vedolizumab) in P-III VARSITY Study for Ulcerative Colitis
Published: May 19, 2019 | Tags: Takeda, Reports, Results, Entyvio, vedolizumab, P-III, VARSITY, Study, Ulcerative Colitis
25. AbbVie Reports Results of Depatux-M (depatuxizumab mafodotin) in P-III INTELLANCE-1 Study for Glioblastoma
Published: May 17, 2019 | Tags: AbbVie, Reports, Results, Depatux-M, depatuxizumab mafodotin, P-III, INTELLANCE-1, Study, Glioblastoma
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com